RepliCel Life Sciences Inc (REPCF)
0.0428
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
RepliCel Life Sciences Total Liabilities (Quarterly): 5.127M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 5.127M |
| June 30, 2023 | 4.942M |
| March 31, 2023 | 4.844M |
| December 31, 2022 | 4.947M |
| September 30, 2022 | 6.754M |
| June 30, 2022 | 6.439M |
| March 31, 2022 | 6.238M |
| December 31, 2021 | 5.831M |
| September 30, 2021 | 5.486M |
| June 30, 2021 | 5.233M |
| March 31, 2021 | 5.277M |
| December 31, 2020 | 4.299M |
| September 30, 2020 | 3.117M |
| June 30, 2020 | 2.806M |
| March 31, 2020 | 2.508M |
| December 31, 2019 | 3.775M |
| September 30, 2019 | 2.509M |
| June 30, 2019 | 2.136M |
| March 31, 2019 | 2.153M |
| December 31, 2018 | 3.836M |
| September 30, 2018 | 1.535M |
| June 30, 2018 | 1.256M |
| March 31, 2018 | 0.9691M |
| December 31, 2017 | 0.9273M |
| September 30, 2017 | 1.029M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.527M |
| March 31, 2017 | 0.5027M |
| December 31, 2016 | 0.4611M |
| September 30, 2016 | 1.518M |
| June 30, 2016 | 1.225M |
| March 31, 2016 | 1.212M |
| December 31, 2015 | 0.7334M |
| September 30, 2015 | 0.4954M |
| June 30, 2015 | 0.583M |
| March 31, 2015 | 0.4103M |
| December 31, 2014 | 0.2886M |
| September 30, 2014 | 0.3121M |
| June 30, 2014 | 0.328M |
| March 31, 2014 | 0.4587M |
| December 31, 2013 | 0.5426M |
| September 30, 2013 | 0.6763M |
| June 30, 2013 | 0.7835M |
| March 31, 2013 | 0.8024M |
| December 31, 2012 | 0.4868M |
| September 30, 2012 | 0.5663M |
| June 30, 2012 | 1.329M |
| March 31, 2012 | 0.9804M |
| December 31, 2011 | 0.2253M |
| September 30, 2011 | 0.2573M |
| June 30, 2011 | 0.1771M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.136M
Minimum
Jun 2019
6.754M
Maximum
Sep 2022
4.570M
Average
4.944M
Median
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| InMed Pharmaceuticals Inc | 2.254M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.2439M |
| Shareholders Equity (Quarterly) | -4.883M |
| Debt to Equity Ratio | -0.0062 |
| Current Ratio | 0.1298 |
| Net Debt Paydown Yield | -0.00% |